Advertisement
Research ArticleArticle

Effect of Cryopreservation on Cytochrome P-450 Enzyme Induction in Cultured Rat Hepatocytes

Ajay Madan, Ryan DeHaan, Dan Mudra, Kathy Carroll, Edward LeCluyse and Andrew Parkinson
Drug Metabolism and Disposition March 1999, 27 (3) 327-335;

Abstract

In the present study, we evaluated the inducibility of cytochrome P-450 (CYP) CYP1A, CYP2B, CYP3A, and CYP4A by β-naphthoflavone, phenobarbital, dexamethasone, and clofibric acid, respectively, in primary hepatocyte cultures prepared from both fresh and cryopreserved rat hepatocytes. Rat hepatocytes were successfully thawed and cultured after cryopreservation in liquid nitrogen for up to 1 month. Percentage of total recovery, viable cell recovery, and final viability of the cells were 68%, 72%, and 85%, respectively. Regardless of whether they were cryopreserved or not, cultured hepatocytes exhibited near-normal morphology. Treatment of cryopreserved hepatocytes with β-naphthoflavone caused an 8-fold increase in 7-ethoxyresorufinO-dealkylase (CYP1A1/2) activity, with an EC50 of 1.5 μM; treatment with phenobarbital caused a 26-fold increase in 7-pentoxyresorufin O-dealkylase (CYP2B1/2) activity, with an EC50 of 10 μM; treatment with dexamethasone caused a 10-fold increase in testosterone 6β-hydroxylase (CYP3A1/2) activity, with an EC50 of 1.3 μM, whereas treatment with clofibric acid caused a 3-fold increase in lauric acid 12-hydroxylase (CYP4A1–3) activity, with an EC50 of 170 μM. The induction of CYP1A, CYP2B, CYP3A, and CYP4A enzymes by these inducers was confirmed by Western immunoblotting. The patterns of P-450 induction in cryopreserved rat hepatocytes, in terms of concentration response, reproducibility, magnitude, and specificity of response, were similar to those observed in freshly isolated hepatocytes. Additionally, the magnitude and specificity of induction was similar to that observed in vivo in rats. In conclusion, under the conditions examined, cryopreserved rat hepatocytes appear to be a suitable in vitro system for evaluating xenobiotics as inducers of P-450 enzymes.

Drugs and new molecular entities are often screened for their ability to induce cytochrome P-450 (CYP)1 and other phase I and II enzymes with the aim of predicting or explaining drug-drug interactions, pharmacokinetic tolerance, and/or formation of liver and thyroid tumors in rodents. Primary cultures of hepatocytes from laboratory animals and humans are reliable in vitro systems for evaluating xenobiotics as inducers of CYP enzymes. Cultured hepatocytes can potentially be used for high-throughput screening of chemical libraries to aid in the selection of drug candidates.

A major problem associated with using primary cultures of human hepatocytes for the aforementioned applications is the erratic supply of human tissue and sample-to-sample variability. Consequently, there is a need for an optimized protocol for the isolation and long-term storage of hepatocytes so that available tissue can be characterized and used more efficiently and conveniently. Cryopreservation is presently the only method for long-term storage of hepatocytes. Several groups have successfully cryopreserved hepatocytes obtained from laboratory animals and humans (Jackson et al., 1985; Chesne and Guillouzo, 1988; Loretz et al., 1989; Sun et al., 1990; de-Sousa et al., 1996; Swales et al., 1996), although their effectiveness, in terms of viable cell recovery and attachment efficiency, vary based on differences in the method used for cryopreservation. These differences include, but are not limited to, cryopreservation medium, hepatocyte density, and the rate at which hepatocytes are frozen. Hepatocytes have been successfully frozen in various media containing 20 to 90% FBS (Chesne et al., 1993) and 10 to 20% DMSO as a cryoprotectant (Loretz et al., 1989). Density of hepatocytes in the freezing media has varied from 106 to 107 cells/ml (Jackson et al., 1985; Chesne and Guillouzo, 1988; Loretz et al., 1989; Chesne et al., 1993;Swales et al., 1996) and, finally, some laboratories use a rapid rate of freezing (Gomez-Lechon et al., 1984), whereas others recommend a slow rate (Loretz et al., 1989). It has been hypothesized that a slower rate of freezing minimizes the formation of intracellular ice crystals, which may be largely responsible for diminished recovery of viable cells from preparations of cryopreserved hepatocytes (Harris et al., 1991). Additionally, rapid thawing of frozen hepatocytes at 37°C is preferred to slow thawing (Chesne and Guillouzo, 1988; Loretz et al., 1989). Depending on the cryopreservation method, viable-cell recoveries from cryopreserved hepatocytes have been reported to range from 40 to 60% (Jackson et al., 1985; Chesne and Guillouzo, 1988; Zaleski et al., 1993; Swales et al., 1996).

A number of studies have evaluated the metabolic capacity of cryopreserved hepatocytes (Utesch et al., 1992; Salmon and Kohl, 1996;Swales et al., 1996). However, little information is available on the inducibility of P-450 enzymes in cryopreserved hepatocytes (de-Sousa et al., 1996). In the present study, we evaluated the inducibility of CYP1A, CYP2B, CYP3A, and CYP4A by β-naphthoflavone, phenobarbital, dexamethasone, and clofibric acid, respectively, in primary hepatocyte cultures prepared from both fresh and cryopreserved rat hepatocytes.

Materials and Methods

Chemicals and Reagents.

Insulin, Dulbecco’s modified Eagle’s medium (DMEM), GlutaMAX-1, modified Chee’s medium (MCM), modified Eagle’s medium (MEM) nonessential amino acids, and penicillin-streptomycin were purchased from Gibco BRL (Grand Island, NY). Matrigel and insulin, transferrin, and selenium were purchased from Collaborative Biomedical Products (Bedford, MA). Collagenase was purchased from Worthington Biochemical Corp. (Freehold, NJ). Vitrogen 100 was purchased from CelTrix (Santa Clara, CA). Androstenedione, l-arginine, bovine albumin, clofibric acid, dexamethasone, DMSO, fetal bovine serum (FBS), EGTA,d-(+)-glucose, glucose 6-phosphate, glucose 6-phosphate dehydrogenase, l-glutamine, 11β-hydroxytestosterone, lauric acid, NADP, β-naphthoflavone, Percoll, phenobarbital, testosterone, thymidine, and trypan blue were purchased from Sigma Chemical Co. (St. Louis, MO). Bicinchoninic acid protein assay reagents were purchased as a kit from Pierce Chemical Co. (Rockford, IL). NuPage gels and related electrophoresis reagents were purchased from Novex (San Diego, CA). Polyvinylidene difluoride membranes were purchased from Bio-Rad (Hercules, CA). 5-Bromo-4-chloro-3-indolyl-phosphate/nitroblue tetrazolium phosphatase substrate was purchased from Kirkegaard & Perry Laboratories (Gaithersburg, MD). 7-Ethoxyresorufin, 7-pentoxyresorufin, and resorufin were purchased from Molecular Probes Inc. (Junction City, OR). [14C]Lauric acid (58 Ci/mol) was purchased from ICN Radiochemicals (Irvine, CA). 6β-Hydroxytestosterone and 16β-hydroxytestosterone were purchased from Steraloids, Inc. (Wilton, NH). Solvents were either purchased from Fisher Scientific (Pittsburgh, PA) or Aldrich Chemical Co. (Milwaukee, WI).

Hepatocyte Isolation and Culture.

Hepatocytes were isolated from male Sprague-Dawley rats by a modification of the previously described two-step collagenase digestion method (Seglen, 1976; Seglen et al., 1980; Quistorff et al., 1989;LeCluyse et al., 1996). Rat livers were first perfused with calcium-free buffer containing 5.5 mM glucose and 0.5 mM EGTA for 10 min at a flow rate of 35 to 40 ml/min and then with buffer containing 1.5 mM calcium and collagenase (0.3–0.4 mg/ml) for 10 to 15 min at a flow rate of 30 to 35 ml/min. Hepatocytes were dispersed from the digested liver in DMEM supplemented with 5% FBS, 6.25 μg/ml insulin, 50 U/ml penicillin, 50 μg/ml streptomycin, and 1 μM dexamethasone and washed by low-speed centrifugation (50g for 2–3 min at room temperature). The cell pellet was resuspended in 1:1 (v/v) mixture of supplemented DMEM and 90% isotonic Percoll and centrifuged (70g for 5 min at room temperature). The cell pellet was resuspended in fresh supplemented DMEM and washed once by low-speed centrifugation. Hepatocytes were resuspended in supplemented DMEM and viability was determined by trypan blue exclusion. Hepatocytes were cultured according to the method described by LeCluyse et al. (1996). Briefly, 3 × 106 hepatocytes were added in 3 ml of supplemented DMEM to 60-mm Permanox plastic culture dishes (Nalge Nunc International, Naperville, IL) coated with a collagen substratum, and allowed to attach for 2 to 3 h at 37°C in a humidified chamber with a 95%/5% mixture of air/CO2. After 2 to 3 h, the culture dishes were gently swirled and medium containing unattached cells was aspirated and discarded. Fresh, ice-cold, serum-free MCM supplemented with 0.1 μM dexamethasone, ITS+ (6.25 μg/ml insulin, 6.25 μg/ml transferrin, 6.25 ng/ml selenium, 5.35 μg/ml linoleic acid, and 1.25 mg/ml albumin), 50 U/ml penicillin, 50 μg/ml streptomycin, and 0.25 mg/ml Matrigel was added to each dish and cultures were returned to the humidified chamber. Medium was changed on a daily basis thereafter. Hepatocytes were maintained in culture for 3 days before treatment withP-450 inducers. On day 4, medium was aspirated and replaced with 3 ml of supplemented MCM containing 0.1% DMSO (negative controls) or one of four P-450 inducers (positive controls). Medium was changed once a day for 3 days before the preparation of microsomes.

Cryopreservation and Thawing.

Hepatocytes were cryopreserved and stored for up to 1 month in liquid nitrogen according to a method based on the method of Ulrich et al. (1998). Briefly, cells were suspended in FBS (containing 10% DMSO) at a density of 1 × 107 cells/ml and were aliquoted (4.5 ml) into Cryotubes (NUNC, Roskilde, Denmark). These vials were placed in a microprocessor-controlled liquid nitrogen freezing chamber (model 1010, Forma, Marietta, OH) and frozen as follows. From 4°C the chamber was cooled at −1°C/min until the sample reached −4°C. The chamber was then cooled at −25°C/min until the chamber temperature reached −40°C (sample temperature of −8 to −10°C). The chamber was then warmed at 15°C/min to −12°C and cooled again at the rate of −1°C/min until the chamber reached −40°C. Finally, the chamber was cooled at −10°C/min until the sample and freezing chamber both reached −90°C at which time the frozen cell suspensions were immediately placed in liquid nitrogen.

After 5 to 30 days in liquid nitrogen, suspensions were thawed in a 37°C water bath. The contents of each tube were mixed with excess supplemented DMEM and washed by low-speed centrifugation. Cell pellets were resuspended in fresh supplemented DMEM and post-thaw viability was determined by trypan blue exclusion. Viable cells were isolated by Percoll centrifugation and cultured as described above.

Cell Harvest and Preparation of Microsomes.

At the end of the culture period, hepatocyte cultures were rinsed twice with ice-cold PBS. An aliquot (0.5 ml) of ice-cold homogenizing buffer (50 mM Tris-HCl, 150 mM KCl, 2.0 mM EDTA) was added to each dish. Cells were scraped from the dishes with a rubber policeman, collected, and homogenized by sonication with a Vibra-cell probe sonicator (Sonics & Materials, Danbury, CT) at approximately 40 W for 15 s. Cell lysates were centrifuged at 9,000g for 20 min at 4°C. Supernatant fractions were collected and centrifuged at 100,000g for 60 min at 4°C. The final microsomal pellets were resuspended in 250 mM sucrose (0.1–0.5 ml) with the aid of a Potter-Elvehjem tissue grinder fitted with a Teflon pestle. A 20-μl aliquot was removed to determine the protein concentration with a bicinchoninic acid protein assay kit, according to Technical Bulletin 23225X from Pierce Chemical Company (Smith et al., 1985; Wiechelman et al., 1988). Microsomal samples were subsequently stored at −80°C.

Enzyme Assays.

The O-dealkylation of 7-ethoxyresorufin and 7-pentoxyresorufin, the 6β- and 16β-hydroxylation of testosterone, and the 12-hydroxylation of lauric acid were determined by methods described previously (Burke and Mayer, 1974; Wood et al., 1983;Sonderfan et al., 1987; Sonderfan and Parkinson, 1988; Romano et al., 1988; Giera and Van Lier, 1991; Burke et al., 1994; Pearce et al., 1996).

Western Immunoblotting.

Microsomal samples were analyzed by Western immunoblotting to determine levels of immunoreactive CYP1A, -2B, -3A, and -4A. Microsomes were subjected to sodium dodecylsulfate-polyacrylamide gel electrophoresis, based on the method originally described by Laemmli (1970). Briefly, microsomes were mixed in a 1:1 ratio with NuPage sample dilution buffer (pH = 8.5) containing 580 mM sucrose, 280 mM Tris-Base, 211 mM Tris-HCl, 2% sodium dodecylsulfate, 1.0 mM EDTA, 50 mM dithiothreitol, and 440 μM Serva Blue G250, and heated at 100°C for 2 to 5 min. The denatured proteins were subjected to electrophoresis on precast 4 to 12% NuPage bis-Tris gels (pH = 6.4 gels; constant voltage of 200 V; electrophoresis time ∼55 min) (Novex, San Diego, CA). Proteins were transferred electrophoretically to polyvinylidene difluoride membranes and subjected to immunoblotting, based on the method byTowbin et al. (1979), with a Blot Module from Novex. Membranes were incubated in blocking buffer containing 10% (w/v) Carnation nonfat dry milk and 0.05% (v/v) Tween 20 in Tris buffered saline (10 mM Tris-HCl and 150 mM NaCl, pH = 7.4) and then probed with polyclonal antibodies raised against purified rat liver microsomal CYP1A1, CYP2B1, CYP3A1 (Parkinson and Gemzik, 1991), or CYP4A1/2 (a gift from Dr. James Hardwick, Northeastern Ohio University, Roostown, OH) at final concentrations ranging from 0.5 to 5 μg/ml. The secondary antibody was affinity purified goat-anti-rabbit IgG (H + L) conjugated with alkaline phosphatase from Kirkegaard & Perry and was diluted in blocking buffer to a final concentration of 0.3 μg/ml. Membranes were washed three times with Tris buffered saline and the proteins visualized by incubation with 5-bromo-4-chloro-3-indolyl-phosphate/nitroblue tetrazolium phosphatase substrate.

Results

Evaluation of Cryopreserved Hepatocytes.

Percentage of total recovery and percentage of viable recovery were estimated in several preparations of cryopreserved hepatocytes. Percentage of total recovery, defined as the total number of cells (dead plus viable) recovered post-thaw compared with the total number of cells frozen, was approximately 68%. Percentage of viable recovery, defined as the number of viable cells recovered post-thaw compared with the number of viable cells frozen, was approximately 72%. Viability of the final preparation of hepatocytes (after Percoll gradient centrifugation) was greater than 85% for each preparation of hepatocytes. Cryopreserved hepatocytes appeared to attach to collagen-coated culture dishes with a slightly lower efficiency than freshly isolated hepatocytes. After 6 days in culture, representative sections of culture dishes seeded with freshly isolated or cryopreserved hepatocytes were photographed under a light microscope (Fig. 1). Regardless of whether they were cryopreserved or not, hepatocytes exhibited near-normal morphology; the cells were cuboidal and contained granular cytoplasm with one or two centrally located nuclei (Fig. 1). In all cases, the cultured hepatocytes were free of detectable autophagic and lipid vesicles. Even though the collagen substratum and Matrigel overlay caused cells to spread and flatten to a certain degree, the hepatocytes remained in chords or trabeculae.

Figure 1
Figure 1

Photomicrographs of primary cultures of rat hepatocytes prepared from freshly isolated (A) and cryopreserved (B) rat hepatocytes.

Cryopreserved or freshly isolated rat hepatocytes were isolated and cultured for up to 6 days as described in Materials and Methods. On day 6, cultures were observed under a phase- contrast microscope and pictures were taken with a 35 mm Nikon camera. Magnification, 61.25×.

Induction of 7-Ethoxyresorufin O-Dealkylase (EROD) (CYP1A1/2) Activity.

The effects of treating freshly isolated or cryopreserved rat hepatocyte cultures with the CYP1A enzyme inducer β-naphthoflavone are shown in Fig. 2, A and B. The induction of EROD (CYP1A1/2) activity by β-naphthoflavone in cryopreserved hepatocytes was concentration dependent with an estimated EC50 of ∼1.5 μM (Fig. 2A). The concentration-response curves for induction of CYP1A1/2 by β-naphthoflavone were quite similar for the cultures prepared from freshly isolated or cryopreserved cells. Furthermore, both the absolute “rates” (expressed as picomole per minute per milligram microsomal protein) and fold induction of CYP1A1/2 by β-naphthoflavone were reproducible between three preparations of cryopreserved rat hepatocytes (Fig. 2B). The magnitude of CYP1A induction in freshly isolated and cryopreserved hepatocytes, on a picomole per minute per milligram basis, was comparable with the response observed in vivo (Table 1).

Figure 2
Figure 2

Effect of cryopreserving rat hepatocytes on the induction of 7-ethoxyresorufin O-dealkylase (CYP1A) activity by β-naphthoflavone.

Cryopreserved or freshly isolated rat hepatocytes were isolated and cultured for up to 6 days as described in Materials and Methods. A, cultures were treated daily for 3 consecutive days with either vehicle (0.1% DMSO) or various concentrations of β-naphthoflavone (0.01, 0.05, 0.1, 0.5, 1.0, 5.0, 10, and 50 μM). B, C, and D, cultures were treated daily for 3 consecutive days with β-naphthoflavone (50 μM), phenobarbital (100 μM), dexamethasone (10 μM), or clofibric acid (100 μM). At the end of the treatment period, hepatocytes were harvested and microsomes were prepared and analyzed for CYP1A activity as described in Materials and Methods. Where error bars are shown, data are mean ± S.D. of three preparations. *p < .05 as determined by ANOVA followed by a Dunnett’s post hoc test.

View this table:
Table 1

Comparison of magnitude of rat P-450 enzyme induction in vivo with that observed in vitro in cultured hepatocytes prepared from freshly isolated or cryopreserved cells

The effects of treating cultured rat hepatocytes with β-naphthoflavone, phenobarbital, dexamethasone, or clofibric acid, prototypical inducers of CYP1A, CYP2B, CYP3A, and CYP4A enzymes, respectively, on EROD activity are shown in Fig. 2, C and D. In cryopreserved hepatocytes β-naphthoflavone (50 μM) caused an 8-fold increase in EROD activity, whereas phenobarbital (100 μM) caused a 3-fold increase. Similar results were obtained with freshly isolated hepatocytes (Fig. 2D). Western immunoblotting established that treatment of cryopreserved hepatocytes with β-naphthoflavone, but not phenobarbital, dexamethasone, or clofibric acid, caused a marked increase in immunoreactive CYP1A1 and CYP1A2 (Fig.3A).

Figure 3
Figure 3

Effect of cryopreserving rat hepatocytes on inducibility of immunoreactive CYP1A1/2 (A), 2B1/2 (B), 3A1/2 (C), and 4A1/2 (D) proteins.

Cryopreserved rat hepatocytes were isolated, cultured for up to 6 days, and treated daily for 3 consecutive days with either vehicle (0.1% DMSO) or prototypical CYP inducers, β-naphthoflavone (β-NF), phenobarbital (PB), dexamethasone (DEX), or clofibric acid (CLOF) (50, 100, 10, and 100 μM, respectively). At the end of treatment period, hepatocytes were harvested. Microsomes were prepared and analyzed by Western immunoblotting as described in Materials and Methods. Gels were loaded with 10 μg/lane (CYP1A and CYP4A) or 5 μg/lane (CYP2B and CYP3A). Samples of rat liver microsomes (RLM) prepared from rats treated with one of four prototypical inducers were also analyzed as reference standards.

Induction of 7-pentoxyresorufin O-dealkylase (PROD) (CYP2B1/2) Activity.

The effects of treating freshly isolated or cryopreserved rat hepatocyte cultures with the CYP2B enzyme inducer phenobarbital are shown in Fig. 4, A and B. The induction of PROD (CYP2B1/2) activity by phenobarbital was concentration dependent, with an estimated EC50 of ∼10 μM (Fig. 4A). The concentration-response curves for induction of CYP2B1/2 by phenobarbital were similar for the cultures prepared from freshly isolated or cryopreserved cells. Furthermore, both the absolute “rates” (expressed as picomole per minute per milligram microsomal protein) and fold induction of CYP2B1/2 by phenobarbital were reproducible between three preparations of cryopreserved rat hepatocytes (Fig. 4B). The magnitude of CYP2B induction in freshly isolated and cryopreserved hepatocytes, on a picomole per minute per milligram, was comparable with the response observed in vivo (Table 1).

Figure 4
Figure 4

Effect of cryopreserving rat hepatocytes on induction of 7-pentoxyresorufin O-dealkylase (CYP2B) activity by phenobarbital.

Cryopreserved or freshly isolated rat hepatocytes were isolated and cultured for up to 6 days as described in Materials and Methods. A, cultures were treated daily for 3 consecutive days with either vehicle (0.1% DMSO) or various concentrations of phenobarbital (5, 10, 20, 50, 100, 250, and 1000 μM). B, C, and D, cultures were treated daily for 3 consecutive days with β-naphthoflavone (50 μM), phenobarbital (100 μM), dexamethasone (10 μM), or clofibric acid (100 μM). At the end of treatment period, hepatocytes were harvested and microsomes were prepared and analyzed for CYP2B activity as described in Materials and Methods. Where error bars are shown, data are means ± S.D. of three preparations. *p < .05 as determined by ANOVA followed by a Dunnett’s post hoc test.

The effects of treating cultured rat hepatocytes with β-naphthoflavone, phenobarbital, dexamethasone, or clofibric acid, prototypical inducers of CYP1A, CYP2B, CYP3A, and CYP4A enzymes, respectively, on PROD (CYP2B) activity are shown in Fig. 4, C and D. In cryopreserved hepatocytes, phenobarbital (100 μM) caused a 26-fold induction of PROD activity, whereas the other inducers had little or no effect. Similar results were obtained with freshly isolated hepatocytes (Fig. 4D). Western immunoblotting established that treatment of cryopreserved hepatocytes with phenobarbital, but not β-naphthoflavone, dexamethasone, or clofibric acid, caused a marked increase in immunoreactive CYP2B1 and CYP2B2 (Fig. 3B).

Induction of CYP2B1/2 in cultured hepatocytes was measured by testosterone 16β-hydroxylase activity. The pattern of induction of testosterone 16β-hydroxylase activity (data not shown) was similar to that shown in Fig. 4D for PROD activity.

Induction of Testosterone 6β-Hydroxylase (CYP3A1/2) Activity.

The effects of treating freshly isolated or cryopreserved rat hepatocyte cultures with the known CYP3A1/22 enzyme inducer dexamethasone are shown in Fig. 5, A and B. The induction of testosterone 6β-hydroxylase (CYP3A) activity by dexamethasone was concentration dependent, with an estimated EC50 of ∼1.3 μM (Fig. 5A). The concentration-response curves for induction of CYP3A1/2 by dexamethasone were similar for the cultures prepared from freshly isolated or cryopreserved cells. Furthermore, both the absolute “rates” (expressed as picomole per minute per milligram microsomal protein) and fold induction of CYP3A by dexamethasone were reproducible between three preparations of cryopreserved rat hepatocytes (Fig. 5B). The magnitude of CYP3A induction in freshly isolated and cryopreserved hepatocytes, on a picomole per minute per milligram, was comparable with the response observed in vivo (Table 1).

Figure 5
Figure 5

Effect of cryopreserving rat hepatoctyes on induction of testosterone 6β-hydroxylase (CYP3A) activity by dexamethasone.

Cryopreserved or freshly isolated rat hepatocytes were isolated and cultured for up to 6 days as described in Materials and Methods. A, cultures were treated daily for 3 consecutive days with either vehicle (0.1% DMSO) or various concentrations of dexamethasone (0.5, 1.0, 5.0, and 50 μM). B, C, and D, cultures were treated daily for 3 consecutive days with β-naphthoflavone (50 μM), phenobarbital (100 μM), dexamethasone (10 μM), or clofibric acid (100 μM). At the end of treatment period, hepatocytes were harvested and microsomes were prepared and analyzed for CYP3A activity as described in Materials and Methods. Where error bars are shown, data are mean ± S.D. of three preparations. *p < .05 as determined by ANOVA followed by a Dunnett’s post hoc test.

The effects of treating cultured rat hepatocytes with β-naphthoflavone, phenobarbital, dexamethasone, or clofibric acid, prototypical inducers of CYP1A, CYP2B, CYP3A, and CYP4A enzymes, respectively, on testosterone 6β-hydroxylase activity are shown in Fig. 5, C and D. In cryopreserved hepatocytes, dexamethasone (10 μM) caused a 10-fold induction of testosterone 6β-hydroxylase activity, whereas phenobarbital (100 μM) caused a 2-fold increase (Fig. 5C). Similar results were obtained with freshly isolated hepatocytes (Fig.5D). Western immunoblotting established that treatment of cryopreserved hepatocytes with dexamethasone and phenobarbital, but not β-naphthoflavone or clofibric acid, caused a corresponding increase in immunoreactive CYP3A1 and CYP3A2 (Fig. 3C).

Induction of Lauric Acid 12-Hydroxylase (CYP4A) Activity.

The effects of treating freshly isolated or cryopreserved rat hepatocyte cultures with the CYP4A enzyme inducer, clofibric acid, are shown in Fig. 6, A and B. The induction of lauric acid 12-hydroxylase (CYP4A1-3) by clofibric acid was concentration dependent, with an EC50 of ∼170 μM (Fig. 6A). The concentration-response curves for induction of CYP4A by clofibric acid were similar for cultures prepared from freshly isolated or cryopreserved cells. Furthermore, both the absolute “rates” (expressed as picomole per minute per milligram microsomal protein) and fold induction of CYP4A by clofibric acid were reproducible between three preparations of cryopreserved rat hepatocytes (Fig. 6B). The magnitude of CYP4A induction in freshly isolated and cryopreserved hepatocytes, on a picomole per minute per milligram, was comparable with the response observed in vivo (Table 1).

Figure 6
Figure 6

Effect of cryopreserving rat hepatocytes on induction of lauric acid 12-hydroxylase (CYP4A) activity by clofibric acid.

Cryopreserved or freshly isolated rat hepatocytes were isolated and cultured for up to 6 days as described in Materials and Methods. A, cultures were treated daily for 3 consecutive days with either vehicle (0.1% DMSO) or various concentrations of clofibric acid (1.0, 5.0, 10, 50, 100, 250, 500, 1500, and 3000 μM). B, C, and D, cultures were treated daily for 3 consecutive days with β-naphthoflavone (50 μM), phenobarbital (100 μM), dexamethasone (10 μM), or clofibric acid (100 μM). At the end of treatment period, hepatocytes were harvested and microsomes were prepared and analyzed for CYP4A activity as described in Material and Methods. Where error bars are shown, data are mean ± S.D. of three preparations. *p < .05 as determined by ANOVA followed by a Dunnett’s post hoc test.

The effects of treating cultured rat hepatocytes with β-naphthoflavone, phenobarbital, dexamethasone, or clofibric acid, prototypical inducers of CYP1A, CYP2B, CYP3A and CYP4A enzymes, respectively, on lauric acid 12-hydroxylase activity are shown in Fig.6, C and D. In cryopreserved hepatocytes, clofibric acid (100 μM) caused a 3-fold induction of lauric acid 12-hydroxylase activity, whereas the other inducers had little or no effect (Fig. 6C). It should be noted that these experiments were carried out with low concentrations of clofibric acid that were not sufficient to cause maximal induction of CYP4A (Fig. 6A). Similar results were obtained with freshly isolated hepatocytes (Fig. 6D). Western immunoblotting established that treatment of cryopreserved hepatocytes with clofibric acid, but not β-naphthoflavone, phenobarbital, or dexamethasone, caused a marked increase in immunoreactive CYP4A proteins (Fig. 3D).

Discussion

Several studies have shown that cryopreserved rat hepatocytes retain adequate viability (Chesne and Guillouzo, 1988; Chesne et al., 1993; de-Sousa et al., 1996; Swales et al., 1996), metabolic competency (Jackson et al., 1985; Utesch et al., 1992; Salmon and Kohl, 1996;Swales et al., 1996), and ability to attach to culture dishes coated with extracellular matrix such as collagen (Utesch et al., 1992;de-Sousa et al., 1996; Salmon and Kohl, 1996; Swales et al., 1996). However, little information is available regarding the inducibility ofP-450 enzymes in cryopreserved hepatocytes. Several factors must be considered when evaluating hepatocytes as an in vitro system for induction studies. These include percentage of recovery of hepatocytes, attachment efficiency to cell culture dishes, morphology of cultured hepatocytes, cell density (confluency), and responsiveness to various P-450 enzyme inducers. These factors have been studied previously with both fresh and cryopreserved hepatocytes (Jackson et al., 1985; Powis et al., 1987; Chesne and Guillouzo, 1988;Loretz et al., 1989; Chesne et al., 1993; de-Sousa et al., 1996), with the exception that cryopreserved hepatocytes have not been evaluated for their responsiveness to inducers of all families ofP-450 enzymes. In the present study, we demonstrate that cryopreserved rat hepatocytes, much like freshly isolated rat hepatocytes, respond to P-450 enzyme inducers when cultured under conditions that restore near-normal cellular morphology. The magnitude of P-450 enzyme induction response in cryopreserved hepatocytes was generally reproducible and was comparable with the response observed in vivo (Table 1).

Data presented in this article show that rat hepatocytes were successfully thawed and cultured after cryopreservation in liquid nitrogen for up to 1 month. Other studies have suggested that cryopreserved hepatocytes, when frozen appropriately, are stable for up to 4 years in liquid nitrogen (Chesne et al., 1993). We have thus far determined that they are stable in liquid nitrogen for up to 3 months (data not shown). Studies are underway to evaluate the effects of long-term storage of cryopreserved hepatocytes. In the current study, the recovery of viable cells was ∼72% (ranging from 53% to 96%) suggesting that, on average, 28% of the viable hepatocytes were lost as a result of freezing, storage, and thawing. Furthermore, attachment efficiency of cryopreserved hepatocytes in culture appeared to be slightly lower than that observed with freshly isolated hepatocytes (data not shown). Both a reduced viable cell recovery and attachment efficiency have been reported previously (Chesne and Guillouzo, 1988;Chesne et al., 1993; Swales et al., 1996). Despite these minor concerns, cryopreserved rat hepatocytes can be cultured and maintained as reliably as freshly isolated hepatocytes.

Regardless of whether the hepatocytes were cryopreserved or not, the constitutive expression of cytochrome P-450 was markedly reduced in culture (Table 1). This is consistent with previous studies in which a decrease in both cytochrome P-450 mRNA (Kocarek et al., 1993) and protein (Woodcroft and Novak, 1998) has been reported within 1 to 2 days of culture. This decrease inP-450 levels is thought to result from the loss of those factors that maintain the constitutive expression of P-450enzymes in vivo. These factors are poorly understood, but are known to include hormones and environmental factors such as diet and, in the case of humans, medications, smoking, and alcohol consumption. This does not present a problem when cultured hepatocytes are used as an in vitro system for the evaluation of drugs and chemicals as inducers ofP-450 enzymes. However, it is for this reason that freshly isolated hepatocytes but not cultured hepatocytes are suitable for in vitro metabolism studies. Although several studies have evaluated the metabolic capacity of hepatocytes (Utesch et al., 1992; Salmon and Kohl, 1996; Swales et al., 1996), it remains to be seen whether hepatocytes cryopreserved according to the method described herein can be used for short-term metabolism studies.

Hepatocyte cultures, irrespective of whether they were seeded with cryopreserved or freshly isolated hepatocytes, were responsive to increasing concentrations of prototypical P-450 inducers. In most cases, a traditional log concentration-response curve was observed (Figs. 2A, 5A, and 6A). A notable exception was the effect of phenobarbital on the expression of CYP2B1/2, which was best characterized by a bell-shaped concentration-response curve (Fig. 4A). Over a concentration range of 10 to 100 μM, phenobarbital caused a concentration-dependent induction of CYP2B activity, as measured by 7-pentoxyresorufin O-dealkylation and testosterone 16β-hydroxylation (data not shown). A plateau was observed at ∼100 μM; a concentration that compares favorably with the plasma concentration in rats administered phenobarbital at sedating dosages of 80 to 100 mg/kg, the dosage range that is typically used to achieve maximal CYP2B induction in vivo. Above 300 μM, the ability of phenobarbital to induce CYP2B activity steadily declined, such that millimolar concentrations of phenobarbital were no more effective than 10 μM phenobarbital at inducing CYP2B enzymes. Attenuation of CYP2B induction at high doses of phenobarbital is not a consequence of cell toxicity and, indeed, millimolar concentrations of phenobarbital are extremely effective at inducing CYP1A1 (data not shown). This phenomenon is not observed in vivo (arguably because millimolar concentrations of phenobarbital cannot be achieved in vivo), but has been reported as an in vitro phenomenon by other investigators (Sidhu et al., 1993). This is substantiated by data shown in Fig. 2, C and D in which a 3-fold induction of EROD by phenobarbital was observed. A practical consequence of the bell-shaped curve shown in Fig. 3A is that artifacts can be observed when high concentrations of a drug or new molecular entity are examined.

The magnitude and specificity of the response of cryopreserved rat hepatocytes to prototypical P-450 enzyme inducers were reproducible from one experimental rat to another (Figs. 2B, 4B, 5B, and 6B) and were similar to those observed in cultures prepared from freshly isolated hepatocytes. This suggests that the process of cryopreservation does not affect the specific drug-cell interactions required for induction of these P-450s in rat hepatocytes.

The patterns of P-450 induction in cryopreserved rat hepatocytes, in terms of concentration response, reproducibility, magnitude of response, and specificity, were similar to those observed in freshly isolated hepatocytes. Furthermore, the magnitude and specificity of induction was similar to that observed in rats in vivo. In conclusion, under the conditions examined, cryopreserved rat hepatocytes appeared to be a suitable in vitro system for evaluating xenobiotics as inducers of P-450 enzymes.

Acknowledgments

We thank Dr. R.G. Ulrich (Abbott Laboratories, Abbott Park, IL) for his advice and assistance regarding hepatocyte cryopreservation procedures. This work was supported in part by a grant from the National Institute of Environmental Health Sciences (ES-03765).

Footnotes

  • Send reprint requests to: Dr. Ajay Madan, XenoTech, LLC, 3800 Cambridge, Kansas City, KS 66103. E-mail: amadan{at}kumc.edu

  • This work was funded in part by Grant ES03765 from the National Institutes of Health.

  • ↵2 The major dexamethasone-inducibleP-450 enzyme in rats was originally named cytochromeP-450p or P-450PCN, and was subsequently renamed CYP3A1 when the cDNA thought to encode this enzyme was isolated and sequenced (Gonzalez et al., 1985). However, it now appears that cytochrome P-450p is encoded byCYP3A23, and that CYP3A1 may be an allelic variant of this gene (Gonzalez et al., 1986; Ribeiro and Lechner, 1992; Kirata and Matsubara, 1993; Komori and Oda, 1994; Nagata et al., 1996; Mahnke et al., 1997; Wang and Strobel, 1997). For simplicity, the old nomenclature has been retained and the major PCN- and dexamethasone-inducible P-450 enzyme will be referred to as CYP3A1.

  • Abbreviations used are::
    CYP
    cytochromeP-450
    DMEM
    Dulbecco’s modified Eagle’s medium
    DMSO
    dimethylsulfoxide
    EC50
    concentration effective in causing 50% of maximal induction
    EROD
    7-ethoxyresorufinO-dealkylase
    FBS
    fetal bovine serum
    MCM
    modified Chee’s medium
    MEM
    modified Eagle’s medium
    PROD
    7-pentoxyresorufinO-dealkylase
    • Received July 20, 1998.
    • Accepted November 24, 1998.

References

  1. ↵
    1. Burke MD,
    2. Mayer RT
    (1974) Ethoxyresorufin: Direct fluorimetric assay of microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab Dispos 2:583–599.
    OpenUrlAbstract
  2. ↵
    1. Burke MD,
    2. Thompson S,
    3. Weaver RJ,
    4. Wolf CR,
    5. Mayer RT
    (1994) Cytochrome P450specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol 48:923–936.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Chesne C,
    2. Guillouzo A
    (1988) Cryopreservation of isolated rat hepatocytes: A critical evaluation of freezing and thawing conditions. Cryobiology 25:323–330.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Chesne C,
    2. Guyomard C,
    3. Fautrel A,
    4. Poullain MG,
    5. Fremond B,
    6. DeJong H,
    7. Guillouzo A
    (1993) Viability and function in primary culture of adult hepatocytes from various species and human beings after cryopreservation. Hepatology 18:406–414.
    OpenUrlCrossRefPubMed
  5. ↵
    1. de-Sousa G,
    2. Langouet S,
    3. Nicolas F,
    4. Lorenzon G,
    5. Placidi M,
    6. Rahmani R,
    7. Guillouzo A
    (1996) Increase of cytochrome P4501A and glutathione transferase transcripts in cultured hepatocytes from dog, monkeys and humans after cryopreservation. Cell Biol Toxicol 12:351–358.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Giera DD,
    2. Van Lier RB
    (1991) A convenient method for the determination of hepatic lauric acid omega-oxidation based on a solvent partition. Fund Appl Toxicol 16:348–355.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Gomez-Lechon MJ,
    2. Lopez P,
    3. Castell JV
    (1984) Biochemical functionality and recovery of hepatocytes after deep freezing storage. In Vitro 20:826–832.
    OpenUrlPubMed
  8. ↵
    1. Gonzalez FJ,
    2. Nebert DW,
    3. Hardwick JP,
    4. Kasper CB
    (1985) Complete cDNA and protein sequence of a pregnenolone-16α-carbonitrile-induced cytochrome P-450: A representative of a new gene family. J Biol Chem 260:7435–7441.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Gonzalez FJ,
    2. Song BJ,
    3. Hardwick JP
    (1986) Pregnenolone-16α-carbonitrile-inducible P-450gene family: Gene conversion and differential regulation. Mol Cell Biol 6:2969–2976.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Harris CL,
    2. Toner M,
    3. Hubel A,
    4. Cravalho EG,
    5. Yarmush ML,
    6. Tompkins RG
    (1991) Cryopreservation of isolated hepatocytes: Intracellular ice formation under various chemical and physical conditions. Cryobiology 28:436–444.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Jackson BA,
    2. Davies JE,
    3. Chipman JK
    (1985) Cytochrome P-450activity in hepatocytes following cryopreservation and monolayer culture. Biochem Pharmacol 34:3389–3391.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Kirata S,
    2. Matsubara T
    (1993) cDNA cloning and characterization of a novel member of steroid-induced cytochrome P4503A in rats. Arch Biochem Biophys 307:253–258.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Komori M,
    2. Oda Y
    (1994) A major glucocorticoid-inducible P450in rat liver is not P4503A1. J Biol Chem (Tokyo) 116:114–120.
    OpenUrl
  14. ↵
    1. Kocarek TA,
    2. Schuetz EG,
    3. Guzelian PS
    (1993) Expression of multiple forms of cytochrome P450mRNAs in primary cultures of rat hepatocytes maintained on matrigel. Mol Pharmacol 43:328–334.
    OpenUrlAbstract
  15. ↵
    1. Laemmli UK
    (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:680–685.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Borchardt RT,
    2. Wilson G,
    3. Smith P
    1. LeCluyse EL,
    2. Bullock P,
    3. Parkinson A,
    4. Hochman JH
    (1996) Cultured rat hepatocytes. in Model Systems for Biopharmaceutical Assessment of Drug Absorption and Metabolism, eds Borchardt RT, Wilson G, Smith P (Plenum Press, New York), pp 121–159.
  17. ↵
    1. Loretz LJ,
    2. Li AP,
    3. Flye MW,
    4. Wilson GE
    (1989) Optimization of cryopreservation procedures for rat and human hepatocytes. Xenobiotica 19:489–498.
    OpenUrlPubMed
  18. ↵
    1. Mahnke A,
    2. Strotkamp D,
    3. Roos PH,
    4. Hanstein WG,
    5. Chabot GG,
    6. Nef P
    (1997) Expression and inducibility of cytochrome P4503A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch Biochem Biophys 337:62–68.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Nagata K,
    2. Murayama N,
    3. Miyata M,
    4. Shimada M,
    5. Urahashi A,
    6. Yamazoe Y,
    7. Kato R
    (1996) Isolation and characterization of a new rat P450(CYP3A18) cDNA encoding P4506β-2 catalyzing testosterone 6β- and 16α-hydroxylation. Pharmacogenetics 6:103–111.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Parkinson A,
    2. Gemzik BG
    (1991) Production and purification of antibodies against rat liver P450enzymes. Methods Enzymol 206:233–245.
    OpenUrlPubMed
  21. ↵
    1. Pearce R,
    2. McIntyre CJ,
    3. Madan A,
    4. Sanzgiri U,
    5. Draper AJ,
    6. Bullock P,
    7. Cook DC,
    8. Burton LA,
    9. Latham J,
    10. Nevins C,
    11. Parkinson A
    (1996) Effects of freezing, thawing, and storing human liver microsomes on cytochrome P450. Arch Biochem Biophys 331:145–169.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Powis G,
    2. Santone KS,
    3. Melder DC,
    4. Thomas L,
    5. Moore DJ,
    6. Wilke TJ
    (1987) Cryopreservation of rat and dog hepatocytes for studies of xenobiotic metabolism and activation. Drug Metab Dispos 15:826–832.
    OpenUrlAbstract
  23. ↵
    1. Pollard JW,
    2. Walker JM
    1. Quistorff B,
    2. Dich J,
    3. Grunnet N
    (1989) Preparation of isolated rat liver hepatocytes. in Methods in Molecular Biology: Animal Cell Culture, eds Pollard JW, Walker JM (Humana Press, Clifton, NJ), 5:151–160.
  24. ↵
    1. Ribeiro V,
    2. Lechner MC
    (1992) Cloning and characterization of a novel CYP3A1 allelic variant: Analysis of CYP3A1 and CYP3A2 sex-hormone-dependent expression reveals that the CYP3A2 gene is regulated by testosterone. Arch Biochem Biophys 292:147–152.
    OpenUrl
  25. ↵
    1. Romano MC,
    2. Straub KM,
    3. Yodis LA,
    4. Eckardt RD,
    5. Newton JF
    (1988) Determination of microsomal lauric acid hydroxylase activity by HPLC with flow-through radiochemical quantitation. Anal Biochem 170:83–93.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Salmon F,
    2. Kohl W
    (1996) Use of fresh and cryopreserved hepatocytes to study the metabolism of pesticides in food-producing animals and rats. Xenobiotica 26:803–811.
    OpenUrlPubMed
  27. ↵
    1. Seglen PO,
    2. Gordon PB,
    3. Poli A
    (1980) Amino acid inhibition of autophagic/lysosomal pathway of protein degradation in isolated rat hepatocytes. Biochem Biophy Acta 630:103–118.
    OpenUrl
  28. ↵
    1. Prescott DM
    1. Seglen PO
    (1976) Preparation of isolated rat liver cells. in Metabolism in Cell Biology, ed Prescott DM (Academic Press, New York), 19:29–83.
  29. ↵
    1. Sidhu JS,
    2. Farin FM,
    3. Omiecinski CJ
    (1993) Influence of extracellular matrix overlay on phenobarbital-mediated induction of CYP2B1, 2B2, and 3A1 genes in primary adult rat hepatocyte culture. Arch Biochem Biophys 301:103–113.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Smith PK,
    2. Krohn RI,
    3. Hermanson GT,
    4. Mallia AK,
    5. Gartner FH,
    6. Provenzano MD,
    7. Fujimoto EK,
    8. Goeke NM,
    9. Olson BJ,
    10. Klenk DC
    (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76–85.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Sonderfan AJ,
    2. Parkinson A
    (1988) Inhibition of steroid 5α-reductase and its effects on testosterone hydroxylation by rat liver microsomal P-450. Arch Biochem Biophys 265:208–218.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Sonderfan AJ,
    2. Arlotto MP,
    3. Dutton DR,
    4. McMillen SK,
    5. Parkinson A
    (1987) Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch Biochem Biophy 265:27–41.
    OpenUrl
  33. ↵
    1. Sun EL,
    2. Aspar DG,
    3. Ulrich RG,
    4. Melchior GW
    (1990) Cryopreservation of cynomologus monkey (macaca fascicularis) hepatocytes for subsequent culture and protein synthesis studies. In Vitro Cell Devel Biol 25:147–150.
    OpenUrl
  34. ↵
    1. Swales NJ,
    2. Luong C,
    3. Caldwell J
    (1996) Cryopreservation of rat and mouse hepatocytes. I. Comparative viability studies. II. Assessment of metabolic capacity using testosterone metabolism. Drug Metab Dispos 24:1224–1230.
    OpenUrlAbstract
  35. ↵
    1. Towbin H,
    2. Staehelin T,
    3. Gordon J
    (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedures and some applications. Proc Natl Acad Sci USA 76:4350–4354.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Ulrich RG,
    2. Cramer CT,
    3. Sun EL,
    4. Bacon JA,
    5. Petrella DK
    (1998) A protocol for isolation, culture, and cryopreservation of hepatocytes from human liver. In Vitro Toxicol 11:23–33.
    OpenUrl
  37. ↵
    1. Utesch D,
    2. Deiner B,
    3. Molitor E,
    4. Oesch F,
    5. Platt KL
    (1992) Characterization of cryopreserved rat liver parenchymal cells by metabolism of diagnostic substrates and activities of related enzymes. Biochem Pharmacol 44:309–315.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Wang H,
    2. Strobel HW
    (1997) Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P4503A9 expressed in Escherichia coli. Arch Biochem Biophys 344:365–372.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Wiechelman K,
    2. Braun R,
    3. Fitzpatrick J
    (1988) Investigation of the bicinchoninic acid protein assay: Identification of the groups responsible for color formation. Anal Biochem 175:231–237.
    OpenUrlCrossRefPubMed
  40. ↵
    1. Wood AW,
    2. Ryan DE,
    3. Thomas PE,
    4. Levin W
    (1983) Regio- and stereoeselective metabolism of two C19 steroids by five highly purified and reconstituted rat hepatic cytochrome P-450isozymes. J Biol Chem 258:8839–8847.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. Woodcroft KJ,
    2. Novak RF
    (1998) Xenobiotic-enhanced expression of cytochromes P4502E1 and 2B in primary cultured rat hepatocytes. Drug Metab Disp 26:372–378.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Zaleski J,
    2. Richburg J,
    3. Kauffman FC
    (1993) Preservation of the rate and profile of xenobiotic metabolism in rat hepatocytes stored in liquid nitrogen. Biochem Pharmacol 46:111–116.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Effect of Cryopreservation on Cytochrome P-450 Enzyme Induction in Cultured Rat Hepatocytes

Ajay Madan, Ryan DeHaan, Dan Mudra, Kathy Carroll, Edward LeCluyse and Andrew Parkinson
Drug Metabolism and Disposition March 1, 1999, 27 (3) 327-335;
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement